Brian McNamee
Chairman bij CSL LIMITED
Vermogen: 24 M $ op 31-03-2024
Profiel
Dr. Brian A. McNamee, MD, is directeur bij Tarnagulla Ventures Pty Ltd. Hij zetelt in de Raad van Bestuur van Zenyth Therapeutics Ltd. Dr. McNamee was voorheen werkzaam als Onafhankelijk Bestuurder bij Gen-Probe, Inc., Chief Executive Officer, Executive Director & MD bij CSL Ltd., President bij ZLB Behring LLC, General Manager-Faulding Product Divisions bij FH Faulding & Co. Ltd., en Managing Director bij Pacific Biotechnology Ltd. Hij was ook lid van de raad van bestuur van Gen-Probe, Inc. en Peter Maccallum Cancer Foundation Ltd. Hij behaalde zijn doctorale graad aan de Universiteit van Melbourne en zijn doctorale graad aan de Universiteit van Melbourne.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CSL LIMITED
0.03% | 16-02-2024 | 126 227 ( 0.03% ) | 24 M $ | 31-03-2024 |
Actieve functies van Brian McNamee
Bedrijven | Functie | Begin |
---|---|---|
ZENYTH THERAPEUTICS LIMITED | Director/Board Member | - |
CSL LIMITED | Chairman | 17-10-2018 |
Geoff Ogilvy Foundation | Chairman | 01-05-2021 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chairman | - |
Eerdere bekende functies van Brian McNamee
Bedrijven | Functie | Einde |
---|---|---|
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Chairman | 01-06-2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | President | 01-07-2013 |
CSL LIMITED | President | 01-07-2013 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Director/Board Member | 31-05-2007 |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | - |
Opleiding van Brian McNamee
University of Melbourne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CSL LIMITED | Health Technology |
Bedrijven in privébezit | 9 |
---|---|
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
FH Faulding & Co. Ltd. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Health Services |
Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Finance |
Geoff Ogilvy Foundation |